eBST Newsletter Monday, Oct 21, 2024 
Monday, Oct 21, 2024 NEWSLETTER
eBST Newsletter Banner
  News Industry Insight Resources Issues  
 
 
 
A study found that COVID-19 vaccinations play a key role in the drop in Long COVID cases, declining with each variant, including pre-Delta, Delta and Omicron eras.   [ Read More ]
 
 
 
 
The Centers for Disease Control and Prevention has launched its Respiratory Illnesses Data Channel for Americans to look up how high or low levels of viruses, such as COVID-19 and influenza, are in their local area for 2024. This year’s new “community snapshot,” which can be located at www.cdc.gov/respiratory-viruses/data/index.html is the CDC's latest attempt to repackage its data in one place for Americans deciding when to take extra precautions recommended in its guidelines, such as masking or testing, as we are headed into the fall and winter.   [ Read More ]
 
 
 
 
Scientists at Kings College London have discovered a novel link between lipids and disorders affecting children’s metabolism that may provide an early warning system for obesity-related problems such as type 2 diabetes, liver and heart disease that could assist medical professionals in facilitating their access to the appropriate treatment by using blood plasma testing machines already in use in hospitals.   [ Read More ]
 
 
 
 
A study conducted by a team of researchers at Newcastle University has identified a novel genetic reason for immunological illnesses — severe combined immunodeficiency (SCID) and Omenn syndrome (OS) — that are uncommon in children, which could lead to early detection and treatment.   [ Read More ]
 
 
 
 
 
 
 
Advancing Your Medical Knowledge Is Easier Than Ever
 
 
 
 
Overhauled and updated, our BioSupply Trends Quarterly website refresh makes staying up to date on medical news and insights accessible and easy. On the new BSTQ, you'll find:
  • Breaking industry news
  • Updates on clinical research, FDA approvals, healthcare regulations and legislation
  • The latest information on disease states, diagnostic tools and therapeutics
  • Facility administration and reimbursement resources
  • Current and past BSTQ issue archives
  • And so much more!
 
 
The same quality content you trust, redesigned with you in mind:  www.bstquarterly.com
 
 
 
 
 
 
 
Industry News
 
 
 
 
The first influenza nasal spray vaccine that can be self-administered has been approved by the U.S. Food and Drug Administration (FDA). FluMist is the first flu vaccine that can be administered without a healthcare provider’s involvement, although it still needs a prescription.   [ Read More ]
 
 
 
The U.S. Food and Drug Administration (FDA) has expanded its approval of Dupixent to chronic obstructive pulmonary disease (COPD). This permits Dupixent’s use as an add-on maintenance treatment of adults whose COPD is inadequately controlled by available therapies. This every-other-week injectable drug is now the first biologic therapy approved by FDA for treating COPD, and is the sixth FDA-approved indication for the drug.   [ Read More ]
 
 
 
The first over-the-counter combination COVID-19 and influenza test, the Healgen Rapid Check COVID-19/Flu A&B Antigen Test, outside of emergency use has been approved by the U.S. Food and Drug Administration. The test is available for those experiencing respiratory symptoms, and it is available without a prescription. While there are other over-the-counter combination tests currently available, this is the first to be marketed to consumers using the traditional approval pathway outside of a public health emergency.   [ Read More ]
 
 
BioSupply Online Ordering
 
 
 
 
 
 
 
IVIG & Albumin Supply Index
 
IVIG: Days On Hand
Albumin: Days On Hand
 
21 Days Supply or Less
22-29 Days Supply
30+ Days Supply
IVIG and Albumin Supply Index represents FFF's aggregate inventory of both products for all our customers who have established product allocations with us (not individual or group allocations).
 
Immune Globulin Products
Albumin Products
 
 
 
What's New at FFF
 
 
 
 
(LONG GROVE PHARMACEUTICALS)
 
 
NOREPINEPHRINE IN SODIUM CHLORIDE injection is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states. It is supplied as a clear, colorless sterile solution in 4 mg/250 mL, 8 mg/250 mL and 15 mg/250 mL non-PVC infusions bags with a single function connector system consisting of a port and cap and packaged in 10 bags of individually aluminum foil pouches.   [ Learn More ]
 
 
 
 
(ENDO INC.)
 
 
ADRENALIN (epinephrine in sodium chloride injection) is a non-selective alpha and beta adrenergic agonist indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. It is supplied as a clear, colorless sterile solution in 2 mg, 4 mg, 5 mg, 8 mg and 10 mg single-dose 250 mL non-PVC infusion bags with a single function connector system consisting of a port and cap, packaged individually in aluminum overwrap with an oxygen scavenger in units of 10.   [ Learn More ]
 
 
 
 
(PFIZER)
 
 
PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W and Y in individuals 10 through 25 years of age. It is supplied in a kit that includes a vial of lyophilized MenACWY component, a prefilled syringe containing MenB component and a vial adapter in cartons of one kit, five kits and 10 kits.   [ Learn More ]
 
 
 
 
(FRESENIUS KABI)
 
 
HYDROMORPHONE HYDROCHLORIDE injection is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which the alternate treatments are inadequate. It is supplied in single dose colorless viles with each mL of sterile, aqueous solution containing 1 mg, 2 mg or 4 mg of hydromorphone hydrochloride with 0.2% sodium citrate and 0.2% citrate acid solution.   [ Learn More ]
 
 
 
 
(BAVARIAN NORDIC INC.)
 
 
JYNNEOS is a vaccine indicated for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. It is supplied in a package of 10 single-dose vials.   [ Learn More ]
 
 
 
 
(BAVARIAN NORDIC INC.)
 
 
RABAVERT is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. It is supplied as a single-dose kit containing one vial of freeze-dried vaccine containing a single dose, one disposable prefilled syringe of sterile diluent for reconstitution (1 mL), one small needle for injection (25 guage, 1 inch), and one long needle for reconstitution (21 gauge, 1½ inches).   [ Learn More ]
 
 
 
 
(EMERGENT TRAVEL HEALTH)
 
 
VIVOTIF (typhoid vaccine live oral Ty21A) is indicated for immunization in adults and children greater than 6 years of age against disease caused by Salmonella typhi. It is supplied in a single foil blister containing four doses of vaccine in a single package.   [ Learn More ]
 
 
 
 
(CUMBERLAND PHARMACEUTICALS)
 
 
VIBATIV is a lypoglycopeptide antibacterial drug indicated for the treatment of the following infections in adult patients caused by designated susceptible bacteria: complicated skin and skin structure infections (cSSSI); and hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates Staphylococcus aureaus. It is supplied in individual cartons of 750 mg single-dose vials; cartons of 12 individually packaged 750 mg single-dose vials; and cartons of four individually packaged 750 mg single-dose vials.   [ Learn More ]
 
 
 
 
(MODERNA)
 
 
MRESVIA is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. It is supplied as a single-dose prefilled plastic syringe in a blister pack containing one dose of 0.5 mL, and in a carton of 10 single-dose prefilled plastic syringes, each syringe containing one dose of 0.5 mL. Each carton contains 5 blisters, and each blister contains two syringes.   [ Learn More ]
 
 
 
 
(INTERNATIONAL MEDICATION SYSTEM)
 
 
REGADENOSON injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. It is supplied as a sterile, preservative-free solution containing 0.08 mg/mL regadenoson in single-dose 5 mL prefilled syringes with a luer-lock fitting.   [ Learn More ]
 
 
 
 
(VALNEVA USA)
 
 
IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. It is supplied in a carton containing one single-dose vial of lyophilized antigen component, live, and one prefilled ungraduated syringe of sterile water diluent component (packaged without needles).   [ Learn More ]
 
 
 
 
(GLAXOSMITHKLINE)
 
 
HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b in children aged 6 weeks through 4 years (prior to fifth birthday). HIBERIX vial and vial presentation is supplied in a carton packaged without syringes or needles containing 10 single-dose vials of lyophilized antigen component and 10 single-dose vials of sterile saline diluent. HIBERIX vial and prefilled syringe presentation is supplied in a carton containing 10 single-dose vials of lyophilized antigen component and 10 single-dose prefilled ungraduated TIP-LOK syringes of sterile saline diluent packaged without needles.   [ Learn More ]
 
 
 
 
(CSL BEHRING)
 
 
ZEMAIRA is an alpha1-proteinase inhibitor (A 1-PI; human) indicated for chronic augmentation and maintenance therapy in adults with A 1-PI deficiency and clinical evidence of emphysema. It is supplied in single-dose vials containing 1,000 mg, 4,000 mg or 5,000 mg functionally active A 1-PI.   [ Learn More ]
 
 
 
 
(PFIZER-BIONTECH)
 
 
COMIRNATY (mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in cartons of 10 single-dose glass prefilled syringes, single-dose plastic prefilled syringes and single-dose vials.   [ Learn More ]
 
 
 
 
(BPI LABS)
 
 
CARBOPLATIN injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents, and for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin. It is supplied in 5 mL fill in 10 mL, 15 mL fill in 20 mL, 45 mL fill in 50 mL and 60 mL fill in 100 mL multiple-dose vials.   [ Learn More ]
 
 
 
 
(NOVAVAX, INC)
 
 
The Novavax COVID-19 Vaccine (Adjuvanted/Protein Subunit) is a vaccine indicated for active immunization to prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in boxes of 10 doses of 0.5 mL Pre-filled Syringes.   [ Learn More ]
 
 
 
 
(GLAXOSMITHKLINE)
 
 
AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied as two components: a single-dose vial of lyophilized antigen component (powder) and a single-dose vial of adjuvant suspension component (liquid) (packaged without syringes or needles) in cartons of 10 vials.   [ Learn More ]
 
 
 
 
(PFIZER INC.)
 
 
ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiration tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied in a kit that includes a vial of lyophilized antigen component, a prefilled syringe containing sterile water diluent component and a vial adapter in cartons of one, five and 10 kits.   [ Learn More ]
 
 
 
 
(ASSERTIO)
 
 
INDOCIN is a nonsteroidal anti-inflammatory drug indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis; moderate to severe osteoarthritis; acute painful shoulder (bursitis and/or tendinitis); and acute gouty arthritis. The 50 mg suppositories (indomethacin suppositories USP) are white, opaque and rectal supplied in boxes of 30.   [ Learn More ]
 
 
 
These products can be ordered from FFF Enterprises' BioSupply Online Ordering System or by calling Wow! Customer Care at  (800) 843-7477.
 
BioSupply Logo
 
Order Online
 
 
 
 
 
 
 
 
Our Magazines
 
BioSupply Trends Quarterly & IG Living Magazine
 
BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. [ BST Quarterly Magazine ]

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers. [ IG Living Magazine ]
 
 
Healthcare Resources
 
Posters, Charts & Brochures
 
FFF Enterprises offers complimentary seasonal vaccine resources to help you with your healthcare practice. [ Order Free Vaccine Resources ]

We also offer BioSupply resources to support the healthcare industry. [ Order Free Resources ]
 
 
Current Medicare IVIG / SCIG Rates
 
 
Rates per gram are effective October 1, 2024, through December 31, 2024
 
 
 
 
Product Offering
J Code
ASP + 6%
(before sequester)
ASP + 4.3%
(after sequester)
IVIG
ALYGLO
J1599
    *    
    *    
ASCENIV 
J1554
$982.81
$967.05
 BIVIGAM 
J1556
$150.34
$147.93
GAMMAGARD SD
J1566
$164.38 
$161.75 
GAMMAPLEX
J1557
$115.85
$113.99
OCTAGAM
J1568
$97.99
$96.42
PANZYGA
J1576
$134.92
$132.76
PRIVIGEN
J1459
$97.16
$95.60
IVIG / SCIG
YUMMIGO
  J1599  
 ** 
**
GAMMAGARD LIQ
  J1569  
 $99.38 
$97.79
GAMMAKED
J1561
$97.61
$96.04
  GAMUNEX-C  
J1561 
$97.61
$96.04
SCIG
CUTAQUIG
J1551
$144.98
$142.65
CUVITRU 
J1555
$168.20
$165.50
HIZENTRA
J1559
$132.32
$130.20
  HYQVIA  
J1575
$175.03
$172.22
XEMBIFY 
J1558
$142.95
$140.66
 
* ASP-based Medicare payment rate not yet available; payment rate assigned by your Medicare Administrative Contractor.
 
 
 
 
Current Issue   Meet the Team
Past Issues   Media Kit
Resources   Editorial Calendar
News   Contact Us
 
 
 
 
 
 
 
 
Manage Communication Preferences, Unsubscribe
44000 Winchester Road, Temecula, CA 92590
©2024 FFF Enterprises, Inc. All Rights Reserved.
Property of FFF Enterprises, Inc.